383 related articles for article (PubMed ID: 17320937)
21. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
22. Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma.
Lim MC; Lee S; Seo SS
Onkologie; 2010; 33(5):260-2. PubMed ID: 20502061
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
24. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract][Full Text] [Related]
26. Salvage cytoreductive surgery for recurrent endometrial cancer.
Bristow RE; Santillan A; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK
Gynecol Oncol; 2006 Oct; 103(1):281-7. PubMed ID: 16631236
[TBL] [Abstract][Full Text] [Related]
27. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
[TBL] [Abstract][Full Text] [Related]
28. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
29. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature.
Chang KL; Crabtree GS; Lim-Tan SK; Kempson RL; Hendrickson MR
Int J Gynecol Pathol; 1993 Oct; 12(4):282-96. PubMed ID: 8253545
[TBL] [Abstract][Full Text] [Related]
30. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features and prognostic factors of endometrial stromal sarcoma: a study of 55 cases].
Shi JL; Cheng NH; Guo LN; Lian LJ
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):517-22. PubMed ID: 22169638
[TBL] [Abstract][Full Text] [Related]
32. Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence.
Koskas M; Morice P; Yazbeck C; Duvillard P; Walker F; Madelenat P
Anticancer Res; 2009 Oct; 29(10):4147-50. PubMed ID: 19846964
[TBL] [Abstract][Full Text] [Related]
33. Endometrial stromal sarcomas--a retrospective analysis of 11 patients.
Diesing D; Cordes T; Finas D; Löning M; Mayer K; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(1B):655-61. PubMed ID: 16739335
[TBL] [Abstract][Full Text] [Related]
34. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.
Shih KK; Yun E; Gardner GJ; Barakat RR; Chi DS; Leitao MM
Gynecol Oncol; 2011 Sep; 122(3):608-11. PubMed ID: 21664663
[TBL] [Abstract][Full Text] [Related]
35. Endometrial stromal sarcoma: a population-based analysis.
Chan JK; Kawar NM; Shin JY; Osann K; Chen LM; Powell CB; Kapp DS
Br J Cancer; 2008 Oct; 99(8):1210-5. PubMed ID: 18813312
[TBL] [Abstract][Full Text] [Related]
36. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
[TBL] [Abstract][Full Text] [Related]
37. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Ann Surg Oncol; 2011 Nov; 18(12):3453-61. PubMed ID: 21541824
[TBL] [Abstract][Full Text] [Related]
38. Low-grade endometrial stromal sarcoma with florid intravenous component.
Lo KW; Yu MY; Cheung TH
Gynecol Obstet Invest; 2008; 66(1):8-11. PubMed ID: 18216492
[TBL] [Abstract][Full Text] [Related]
39. Endometrial stromal sarcoma resembling adenomyosis and menstrual-phase endometrium.
Brunisholz Y; Miller J; Scurry J; Proietto A
Gynecol Oncol; 2004 Oct; 95(1):256-9. PubMed ID: 15385142
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.
Dai Q; Xu B; Wu H; You Y; Li L
Int J Surg; 2024 Apr; 110(4):1919-1928. PubMed ID: 38329091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]